Aphria Inc. (T:APHA*CA)

Business Focus: Alternative Medicine

Sector:  Healthcare Industry:  Pharmaceuticals
 
See Regulatory Filings on SEDAR
Company Contact
Address: 245 Talbot St W Suite 103
LEAMINGTON ON N8H 1N8
Tel: N/A
Website: https://www.aphria.com
IR: See website
<
Key People
Irwin David Simon
Chairman of the Board, interim Chief Executive Officer, Independent Director
John Cervini
Co-Founder and VicePresident-Infrastructure and Technology, Director
Carl A. Merton
Chief Financial Officer
James Meiers
Chief Operating Officer
Brett D. Marchand
Senior Vice President - Supply Chain
Tim Purdie
Chief Information Officer and Chief Information Security Officer
MEGAN Mccrae
Vice President of Marketing
Maureen Berry
Vice President, Corporate Human Resources
 
Business Overview
Aphria Inc is a Canada-based company, which is engaged in producing and selling cannabis. Through its subsidiary Broken Coast Cannabis Ltd and Aphria One facility, the Company produces and sells medical and recreational cannabis. Aphria One serves as the basis, on which the Company develops techniques in cultivation, extraction and processing cannabis. The purpose-built, indoor cannabis production facility of Broken Coast Cannabis Ltd provides the Company with B.C. Bud cannabis brand. Broken Coast cannabis is grown on the shores of the Salish Sea in small batches by choice, using single-strain rooms. Through its subsidiary and international organization Aphria International, the Company is focused on building a global cannabis brand. Solei Sungrown Cannabis is the Company's first adult-use brand. The Company has presence in more than 10 countries across 5 continents.
Financial Overview
For the nine months ended 28 February 2019, Aphria Inc revenues increased from C$24.9M to C$108.5M. Net loss totaled C$32.3M vs. income of C$34.4M. Revenues reflect Revenue from cannabis produced increase from C$24.9M to C$52.8M. Net loss reflects Share-based compensation increase from C$10.7M to C$23M (expense), Selling, marketing and promotion increase from C$7.8M to C$20M (expense).
Reporting Currency: Canadian Dollars
Enterprise value: $2,030M as of Feb 28, 2019
Annual revenue (TTM): $120.57M as of Feb 28, 2019
EBITDA (TTM): -$80.45M as of Feb 28, 2019
Net annual income (TTM): -$37.25M as of Feb 28, 2019
Free cash flow (TTM): -$268.06M as of Feb 28, 2019
Net Debt Last Fiscal Year: N/A
Shares outstanding: 250,989,120 as of Jul 2, 2019
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization